La Roche-Posay Appears in 92.1% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Answer Capsule

In November 2026, La Roche-Posay appeared in 712 of 773 AI answers included in the Dermatologist Recommended Skin Care Brands benchmark (92.11%). It received 541 recommendations (69.99%), with 312 Top 3 placements and 110 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. The historical results show how the figures changed across available months. Different monthly samples limit those comparisons, and conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

• How do La Roche-Posay mentions, recommendations and placements compare with its Dermatologist Recommended Skin Care Brands peers?

La Roche-Posay recorded 712 mentions (92.11%) and 541 recommendations (69.99%) across 773 answers included in the benchmark. Top 3 placements numbered 312; first-place recommendations numbered 110. Framing among its mentions was 564 positive, 148 neutral and 0 negative.

La Roche-Posay sits near the top of this category on reach, appearing in almost every answer, but its recommendation share trails the leader by a clear margin. The gap between being mentioned and being actively endorsed is where the commercial opportunity lives.

Placement tells a similar story. The brand earns many shortlist positions but converts far fewer into first-place picks, so answers often treat it as a safe option rather than the standout choice. Proposed work should focus on what earns affirmative endorsement, not just presence.

Framing is overwhelmingly positive with no negative mentions recorded, which suggests the brand is well regarded but not always chosen. That distinction is worth testing against the specific questions where it appears.

What changed since last month

Questions This Section Answers

• How did La Roche-Posay counts and coverage differ across the available monthly snapshots?

From October 2026 to November 2026, La Roche-Posay's mention count fell from 728 to 712, while its recommendation count fell from 715 to 541. The recommendation rate was 92.86% and 69.99% respectively.

The November sample shows a marked drop in recommendations and shortlist placements compared with October, while mentions eased only slightly. The movement is large enough to warrant attention, but the monthly samples are separate selections, so the change cannot be attributed to any single cause.

October's figures were unusually strong across recommendations and placements, making November's return look sharper by contrast. Because the answer sets differ between months, the comparison describes what was recorded rather than explaining why it shifted.

Proposed work should treat this as a prompt to re-examine the questions and sources behind the weaker month, not as evidence that anything on the brand's side changed.

Step 1. Measure

Questions This Section Answers

• What should the agency measure and verify first for La Roche-Posay?

AI answers contained 6 conflicting claims about La Roche-Posay: 0 critical, 2 high, 4 medium, 0 low. Of these, 2 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

A visibility comparison would show where La Roche-Posay is endorsed versus merely mentioned, helping the client decide which questions deserve attention first. Pairing that with a short list of claims to fact-check turns a broad concern into a manageable set of tasks.

The recorded conflicts cluster around cleanser and moisturizer pricing, with a couple rated high priority. Those ratings order the fact-checking work; they do not show that the company or any publisher got something wrong.

Proposed work is a scorecard plus a scoped fact-review list, each item assigned an owner and an evidence requirement before anyone drafts a correction.

Step 2. Make the website consistent

Questions This Section Answers

• Which recorded claim differences about La Roche-Posay should be verified before proposed page edits?

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

The disputed topics center on pricing for the Toleriane cleanser and Double Repair moisturizer, where recorded answers give different figures. Both columns quote AI answers, not verified company facts, so the first step is confirming the entity, the date and the source behind each figure.

Different dates can explain an apparent conflict, and a price quoted for one size or retailer may not contradict another. Proposed work is to verify each claim against current primary sources before deciding whether any page needs changing.

Where verification supports an edit, a page brief would set out the approved facts and wording. Where it does not, the item closes with a documented no-change decision.

Step 3. Align the external narrative

Questions This Section Answers

• Which cited third-party pages are relevant to fact review for La Roche-Posay?

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

Several widely cited review pages are linked to the conflicting claims, with the most-cited cleanser roundup associated with the largest share. That makes these pages sensible places to start a source review, though a linked page is not necessarily the cause of a claim.

Proposed work is to check each page's current contents and note what it actually says about the brand and its products. Only where a genuine discrepancy is confirmed would the agency prepare an evidence-backed request to the publisher.

Requests should be framed as offers of accurate information, not as assumptions of error, and responses recorded alongside the original finding.

Step 4. Optimize priority company pages

Questions This Section Answers

• Which observed La Roche-Posay website pages should receive review briefs?

The company's website was cited 36 times across 28 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

The brand's own pages are cited across a modest set of addresses, with the Toleriane cleanser page drawing the most appearances. That page is the natural first candidate for a brief, given its link to the disputed pricing topics.

Proposed work is to draft page briefs that pair approved product facts with the questions buyers actually ask, starting with the pages already earning citations. Pages with no recorded recommending answers are lower priority until their content is reviewed.

A cited page is not automatically one that accompanied a recommendation, so briefs should aim to strengthen clarity rather than chase citation counts.

Step 5. Publish around buyer questions

Questions This Section Answers

• Which observed buyer questions support content briefs for La Roche-Posay?

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The recorded questions are broad category and routine queries: top brands, dermatologist recommendations, best body lotions and cleansers, and what to use with tretinoin. These are the moments where the brand is being weighed against rivals.

Proposed work is to check existing coverage first, then draft buyer-question content only where a genuine gap exists. Briefs would answer the question directly and give the brand a clear reason to be chosen, not just listed.

These observations reflect recorded answers, not search volume, so content priorities should be confirmed with the client before drafting begins.

Our 90-day action plan

Questions This Section Answers

• How should the agency sequence the proposed La Roche-Posay work and judge completion?

The first month establishes the baseline scorecard, a scoped fact-review list and a shortlist of pages and sources, each with an owner and review status. This gives later work a documented starting point.

The second month produces approved page briefs and justified publisher requests, with confirmed edits, no-change decisions and responses tracked separately. The third month adds buyer-content briefs and a fresh scorecard.

Delivered work will be recorded separately from measured answer outcomes, and no visibility gain is promised. The scorecard shows what changed, with the comparability limits stated alongside.

Methodology

Questions This Section Answers

• How are La Roche-Posay answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 773 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5811 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

The report covers a single month, and the exact dates the original answers were collected have not been verified. Recommendation requires both an endorsement and positive wording, and placement counts sit inside recommendations rather than adding to them.

Answers can mention several companies, so company counts do not sum to distinct answers. Monthly samples differ, so comparisons show what was recorded, not why it changed. Cited pages and disputed claims still need independent verification.

Our first three priorities

First, verify the disputed pricing claims against current primary sources before any correction is considered, and close items that cannot be confirmed. Second, review the most-cited external pages to see what they currently say, then prepare evidence-backed requests only where a real discrepancy exists.

Third, draft page briefs for the brand's most-cited pages and for the buyer questions where it is mentioned but not chosen, checking existing coverage first. Each step has a named owner and a documented outcome, so the client can see what was confirmed, what was declined and what remains open.